The promising results of TSPO PET imaging to diagnose and characterize some PSIDs and especially atherosclerosis [122] lead us to think that, as in some central nervous system disorders such as multiple sclerosis and amyotrophic lateral sclerosis [39], a clinical application of TSPO as a biomarker of inflammation is possible. This evidence concerns the gene TSPO and atherosclerosis.